Women can have safe pregnancies after breast cancer treatment
Full article: https://www.abstractsonline.com/pp8/#!/9223/presentation/677
In a large analysis of all published studies to date, most women who become pregnant after breast cancer treatment had safe pregnancies, with no increase in their cancer recurrence risk. Infants of mothers treated for breast cancer were more likely to have low birth weight, preterm birth and small size at birth but there was no increase in birth defects. Breast cancer survivors who became pregnant had a similar risk of recurrence and survival as survivors who did not become pregnant. (posted 6/24/21)
Este artículo está disponible en español.
Questions To Ask Your Health Care Provider
- I am about to begin treatment for breast cancer:
- What options do I have to preserve my fertility?
- Which treatments are most likely to affect my fertility?
- Can you refer me to an oncofertility expert?
- I have been treated for breast cancer:
- What are my chances of becoming pregnant given my personal history?
- How long should I wait to pursue a pregnancy?
- What are the risks (or benefits) of a pregnancy?
- What are the risks of pregnancy complications?
- What are the risks of infant safety issues? How significant are these likely to be?
- If I chose to become pregnant after my breast cancer treatment, what issues should I consider about the management of my pregnancy?
Open Clinical Trials
The following research studies related to fertility preservation are enrolling patients.
Fertility preservation studies for women
Fertility preservation for men
- NCT02972801: Testicular Tissue Cryopreservation for Fertility Preservation. Testicular tissue cryopreservation is an experimental procedure where testicular tissue is retrieved and frozen. This technique is reserved for young male patients, with the ultimate goal that their tissue may be used in the future to restore fertility when experimental techniques emerge from the research pipeline.
FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.